About
Technology
Issues
FAQ
Links
Official Page
Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
